Stay updated on EN3835 for Cellulite in Women Clinical Trial
Sign up to get notified when there's something new on the EN3835 for Cellulite in Women Clinical Trial page.

Latest updates to the EN3835 for Cellulite in Women Clinical Trial page
- ChecktodayChange DetectedEndo USA Inc., a Keenova Therapeutics Company, is added as the sponsor, replacing Endo Pharmaceuticals. The page revision has been updated from v3.5.4 to v3.5.5.SummaryDifference0.3%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThere are no textual changes to report on this page; the study details and content remain unchanged, retaining the previously published information.SummaryDifference0.0%

- Check22 days agoChange DetectedThe study documentation revision tag was updated from v3.5.3 to v3.5.4. This reflects a new release version of the materials.SummaryDifference0.1%

- Check44 days agoChange DetectedA minor update to the page’s software/version label occurred, advancing the revision from v3.5.2 to v3.5.3 without changing the study details shown.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision: v3.5.0 has been added to the revision history, and the previous entry Revision: v3.4.3 has been removed.SummaryDifference0.0%

Stay in the know with updates to EN3835 for Cellulite in Women Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EN3835 for Cellulite in Women Clinical Trial page.